Streptomycin Sulfate
Streptomycin Sulfate (CAS: 3810-74-0) is the sulfate salt of streptomycin, an aminoglycoside antibiotic produced by Streptomyces griseus. It acts by binding to the 30S ribosomal subunit, causing misreading of mRNA and inhibiting protein synthesis in susceptible bacteria, with activity against Mycobacterium tuberculosis and various Gram-negative pathogens. Historically the first effective antitubercular agent, it remains a component of multi-drug regimens for drug-resistant tuberculosis treatment. Veterinary medicine employs it for bacterial infections in livestock and companion animals, while laboratory research uses it as a selection antibiotic in cell culture and microbiological studies. The sulfate salt provides improved solubility and stability for injectable formulations. As a potent antibiotic, its use is regulated and reserved for specific indications to preserve efficacy and minimize resistance development.
– Tuberculosis Treatment: Used in combination regimens for drug-sensitive and drug-resistant TB as a second-line injectable agent.
– Veterinary Medicine: Applied in treating bacterial infections in cattle, swine, and poultry under veterinary supervision.
– Laboratory Research: Serves as a selection antibiotic in bacterial culture and molecular biology applications requiring aminoglycoside resistance markers.
– Agricultural Applications: Employed in plant disease control formulations for bacterial infections in crops.
Product Name: Streptomycin Sulfate
For global customers, we provide complete technical documentation to support product evaluation, regulatory compliance and safe handling during transportation and application.